MedTrace Logo

Characteristics of Patients With Hypersensitivity Reactions to Intravenous Iron Infusions

NCT04359368 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 42

Last updated 2020-04-24

No results posted yet for this study

Summary

This study aims to evaluate characteristics of patients with previous hypersensitivity reaction grades I-IV to intravenous ferric carboxymaltose (Ferinject) or to iron sucrose (Venofer) including age, atopy status, previous allergic reactions, previous medical history, current medications and co-morbidities. Furthermore, symptoms on reaction such as severity grade of reaction will be evaluated.

Conditions

  • Iron-deficiency
  • Hypersensitivity Reactions

Interventions

OTHER

collection of patient data

Data collection (history, clinical presentation, medication, complications, laboratory testing) will be performed from patient records stored in the protected electronic patient system ISMed (Integrated System for Medical Diagnostic) of patients with HSRs to NDIPs.

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Esther Steveling-Klein, Dr. med · Allergology, University Hospital Basel

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-01
Primary Completion
2019-10-31
Completion
2019-10-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04359368 on ClinicalTrials.gov